Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-4.48%
operating margin TTM
-4.25%
revenue TTM
200.24 Million
revenue per share TTM
3.99$
valuation ratios | |
|---|---|
| pe ratio | -194.13 |
| peg ratio | -4.46 |
| price to book ratio | 14.41 |
| price to sales ratio | 8.70 |
| enterprise value multiple | 323.37 |
| price fair value | 14.41 |
profitability ratios | |
|---|---|
| gross profit margin | 80.76% |
| operating profit margin | -4.25% |
| pretax profit margin | -4.11% |
| net profit margin | -4.48% |
| return on assets | -2.77% |
| return on equity | -8.53% |
| return on capital employed | -3.47% |
liquidity ratios | |
|---|---|
| current ratio | 2.67 |
| quick ratio | 2.55 |
| cash ratio | 1.44 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 90.55 |
| operating cycle | 176.90 |
| days of payables outstanding | 34.98 |
| cash conversion cycle | 141.92 |
| receivables turnover | 4.23 |
| payables turnover | 10.43 |
| inventory turnover | 4.03 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.38 |
| debt equity ratio | 1.02 |
| long term debt to capitalization | 0.50 |
| total debt to capitalization | 0.50 |
| interest coverage | -1.54 |
| cash flow to debt ratio | 0.17 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.09 |
| cash per share | 7.64 |
| operating cash flow per share | 1.11 |
| free cash flow operating cash flow ratio | 0.98 |
| cash flow coverage ratios | 0.17 |
| short term coverage ratios | 26.10 |
| capital expenditure coverage ratio | 58.52 |
Frequently Asked Questions
When was the last time Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) reported earnings?
Mirum Pharmaceuticals, Inc. (MIRM) published its most recent earnings results on 04-11-2025.
What is Mirum Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)'s trailing twelve months ROE is -8.53%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Mirum Pharmaceuticals, Inc. (MIRM) currently has a ROA of -2.77%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MIRM's net profit margin stand at?
MIRM reported a profit margin of -4.48% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MIRM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.67 in the most recent quarter. The quick ratio stood at 2.55, with a Debt/Eq ratio of 1.02.